The effect of Kawasaki disease on childhood allergies - a sibling control study

Woei Kang Liew1, Chee Wen Terence Lim, Teng Hong Tan

  • 1Department of Paediatrics Medicine, KK Women's & Children's Hospital, Singapore. liew.woei.kang@kkh.com.sg

Insights

Children with Kawasaki disease (KD) show a higher risk of developing allergic diseases, contrary to initial hypotheses. This suggests KD may predispose individuals to immune system imbalances leading to allergies.

Area of Science:

  • Pediatric Immunology
  • Allergy and Immunology
  • Rheumatology

Background:

  • Kawasaki disease (KD) is a childhood vasculitis characterized by immune activation.
  • Previous hypotheses suggested KD might reduce the risk of allergic diseases.

Purpose of the Study:

  • To investigate the association between Kawasaki disease and the risk of developing allergic diseases in children.
  • To test the hypothesis that KD confers a lower risk of subsequent allergic conditions.

Main Methods:

  • A cross-sectional study comparing children with a history of KD to their healthy siblings.
  • Standardized International Study of Asthma and Allergies in Childhood (ISAAC) questionnaires, physical examinations, and skin prick tests were used.
  • Statistical analyses included McNemar's test and multivariable logistic regression to adjust for age and gender.

Main Results:

  • Allergic rhinitis was significantly more prevalent in children with KD compared to controls (adjusted OR=2.90).
  • Children diagnosed with KD after 12 months of age showed increased rates of allergic rhinitis, 'any' allergies, and Blomia tropicalis sensitization.
  • KD patients without coronary artery abnormalities exhibited higher risks of allergic rhinitis and 'any' allergies.

Conclusions:

  • Kawasaki disease appears to be a risk factor for developing subsequent allergic diseases.
  • The findings suggest that KD may occur in children prone to immune dysregulation, leading to inflammatory responses and later allergic manifestations.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma